Doernbecher Pediatric HematologyOncology Fellowship Program

1
DoernbecherPediatric Hematology/OncologyFellowsh
ip Program
2008
2
History

• Current 3-yr program ACGME-approved in 1997
• Established by Len Johnson and Gary Jones
• First fellow entered program in July 2000
• Kiwanis Clubs of OR and SW WA support 2 positions
  yearly, growing an endowment
• Grass roots fund raising
• Other funding GME, DCH, NRSA, St Baldricks
• 2 first year and 6 total fellows now each year

3
Applicants

• NRMP since 2001
• ERAS starting 2009
• For 2 entry positions July 2009
• 42 applicants
• 14 interviewed
• 4-yr Adolescent Young Adult fellowship
• for entry 7-09
• combined medical oncology PHO

4
Residency Training Programs of our PHO Fellows
5
PHO Fellowship Programs National Data
For starting date 7-08 150 applicants 129
positions 54 programs (1 6 positions/yr) ?
from 119 applicants for 7/05
6
15 PHO Faculty
H.S. Nicholson
L Stork
L Wolff
D Tilford
G Thomas
T Lamkin
S Malempati
B Chang
P Kurre
E Nemecek
R Trueworthy
M Recht
K Nazemi
R Butler
S Lindemulder
7
PHO Clinical and Research Programs

• Leukemia Lymphoma
• Linda Stork Bill Chang
• Neuro-Oncology
• Kelly Nazemi Kathy Perko, RN, PNP Stacy
  Nicholson
• Solid Tumors
• Suman Malempati Thomas Lamkin
• Stem Cell Transplant
• Eneida Nemecek Peter Kurre
• Tara Berhardt, RN, PNP Amy Kenagy, RN, PNP
• Hemophilia Non-Malignant Blood Disorders
• Michael Recht Greg Thomas
• Palliative Care
• Greg Thomas Kathy Perko, RN, PNP

8
PHO Programs (cont)

• Investigational Therapeutics
• Suman Malempati Linda Stork
• Survivorship
• Susan Lindemulder Larry Wolff Kelly Anderson,
  RN, FNP
• Adolescent Young Adult
• Susan Lindemulder Kelly Anderson, RN, FNP
• Neuropsychology
• Robert Butler, PhD
• Bone Marrow Failure
• Peter Kurre
• Lab-based Research
• Peter Kurre Bill Chang

9
(No Transcript)
10
Some of our 2007 Team
11

• Purpose - To Train Fellows to
• Deliver exceptional patient care
• Treat children
• Support families
• Engage in scholarship and research
• Treat, cure, and prevent
• Cancers and blood disorders
• Improve the quality of a childs long life
• Teach
• Students, residents, fellows, RNs
• Colleagues
• Patients and families

12
Training Program

• First year
• Clinical rotations, continuity clinics
• Week day night and weekend call
• One month Research Development
• Choose lab mentor before 2nd year
• Second and Third Years
• 80 research translational lab-based or
  clinical, or MPH
• Human Investigation Program x 2 years
• Continuity clinic ½ day each week
• Week day night and weekend call

13
Dr. Suman Malempati
Learn From Patients
14
Learn From Clinical Mentors and Other Fellows
15
Dr. Veronica Flood
Learn in the Lab
16
Learn From Other Subspecialists
17
Fellows Research Projects and Mentors

• Grover Bagby, MD Fanconi genes and cancer
• Sri Nagalla, MD, PhD Gaba receptors in
  neuroblastoma
• Rosalie Sears, PhD C-Myc stabilization
• Dave Farrell, PhD Dysfibrinogenemia
• Mather Thayer,PhD Chromosone instability
• Rosalie Sears, PhD C-Myc in brain tumors
• Scott Howard, MD (St Judes) Hodgkins
  lymphoma RX in developing countries
• Michael Deininger, MD, PhD Tyrosine kinase
  inhibitors in CML

18
Fellows Research Projects and Mentors

• Sri Nagalla, MD, PhD genomics and proteomics
  of neuroblastoma
• Dan Marks, MD, PhD Glucose Tolerance in ALL
  survivors
• James Huang, MD In Vitro Drug Sensitivity of
  ALL blasts
• Eneida Nemecek, MD BMT toxicities in AYAs
• Michael Deininger, MD, PhD Leukemia inhibitors
• Grover Bagby, MD Fanconi proteins and
  informatics

19
Where have they gone after training?
20
10 graduates as of July 2008

• 100 PHO Boards passing rate

21
What motivates our fellows to work so hard?
Kids like these